Pronóstico de stock pgnx
1/1/2020 · Here is What Hedge Funds Think About Progenics Pharmaceuticals, Inc. (PGNX) "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). 8/1/2018 · Progenics Pharmaceuticals received a critical approval from the FDA on Monday. The shares have dropped some 10% since then in some buy the rumor, sell the news PGNX Real Time Stock Quote - Get Progenics Pharmaceuticals Inc. Common Stock (PGNX) last sale data in real-time at NASDAQ.com. PGNX stock forecast Our latest prediction for Progenics Pharmaceuticals, Inc.'s stock price was made on the Sept. 9, 2019 when the stock price was at 5.01$. In the short term (2weeks), PGNX's stock price should outperform the market by 3.46%. 12/11/2018 · Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 1/1/2020 · Stock analysis for Progenics Pharmaceuticals Inc (PGNX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and Find out if PGNX is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on PGNX.
View Progenics Pharmaceuticals' (NASDAQ:PGNX) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat.
8/9/2017 · Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today The market couldn't see past a precipitous drop in royalty revenue during the first quarter. Progenics Pharmaceuticals, Inc. (PGNX) is trending up in the market in today’s trading session. The stock, focused in the biotechnology space, is currently trading at $5.50 after gaining 11.11% so far today. As it relates to biotech stocks, there are several aspects that have the potential to lead to movement in the market. Myriad Genetics co-founder Walter Gilbert bought $150K of MYGN. It was the Nobel Laureate's first ever open market buy of the stock. via whalewisdomalpha 12/17/2019; Investors Are Fleeing Starbucks’ Stock 12/16/2019; Engine Capital filed a 13D on CymaBay. CBAY dropped 75% after halting drug trial, trades at 2/3 of net cash. 12/27/2019 · PGNX: Get the latest Progenics Pharmaceuticals stock price and detailed information including PGNX news, historical charts and realtime prices. TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period. FactSet calculates the Market Cap for the basic symbol to include common shares only.
1/1/2020 · Stock analysis for Progenics Pharmaceuticals Inc (PGNX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and
Progenics (PGNX) delivered earnings and revenue surprises of 18.52% and -20.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? PGNX. earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Stock screener for investors and traders, financial visualizations.
Review PGNX dividend yield and history, to decide if PGNX is the best investment for you. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
8/9/2019 · Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Find the latest analyst research for Progenics Pharmaceuticals Inc. Common Stock (PGNX) at Nasdaq.com. 20 Dec 2019 Real-time trade and investing ideas on Progenics Pharmaceuticals Inc. PGNX from the largest community of traders and investors.
Find real-time PGNX - Progenics Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Progenics (pgnx) stock soars as relistor receives fda approval. By Rachel Graf. Jul 20, 2016 12:46 PM EDT. MARKETS. Stocks move higher as crude oil pares losses. PGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average. Review PGNX dividend yield and history, to decide if PGNX is the best investment for you. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. In addition, this page includes various stock data for Progenics Pharmaceuticals, such as the latest Progenics Pharmaceuticals stock price history, total returns, stock price today in addition to fundamental data such as earnings and dividends as well as valuation measures such as dividend yield and PE ratio. Auf dieser Webseite können Sie sehen, dass #stockmarket Hashtag Fotos und Videos zu Instagram - Twitter enthält.